Newsfiscal.ai
Phio Pharmaceuticals Announces Participation in Renmark Financial Communications Virtual Non-Deal Roadshow
· Published
Article summary
Phio Pharmaceuticals Corp. announced that its CEO and Chairman, Robert Bitterman, will present an overview of the company's INTASYL siRNA therapeutic platform at a virtual non-deal roadshow.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…